Loading...
Arcadia Biosciences Community
NasdaqCM:RKDA Community- 1 Narratives written by author
- 1 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
Community Investing Ideas
Zola Distribution Expansion Will Unlock Enduring Market Strength
Key Takeaways Arcadia's focus on expanding Zola distribution and profitable product lines is set to drive revenue growth and improve earnings through high-margin sales. Strategic exits and IP monetization simplify operations, reduce expenses, and provide capital for growth, enhancing long-term financial stability.Read more
0users have liked this narrative
1users have commented on this narrative
0users have followed this narrative
AN
US$12
68.6% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
25.04% p.a.
Profit Margin
6.21%
Future PE
22.25x
Share price in 2028
US$10.64